SCHEMBL23322753

SCHEMBL23322753

N#Cc1ccc(N2CC3CCC(C2)N3C=O)nc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.45
GRM4 Q14833 1/20 0.44
CHRM1 P11229 1/20 0.43
PARP1 P09874 2/20 0.43
TNK1 Q13470 2/20 0.43
PANK3 Q9H999 4/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SPR P35270 1/20 0.41
DPP4 P27487 6/20 0.40
DPP8 Q6V1X1 4/20 0.40
DPP9 Q86TI2 4/20 0.40
DPP7 Q9UHL4 3/20 0.40
PREP P48147 1/20 0.39
CHRM4 P08173 1/20 0.39
CYP11B2 P19099 1/20 0.38
CHRM2 P08172 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26124147 0.80 CHRM1 (0.52) GPR119GRM4CHRM1PARP1TNK1
SCHEMBL18701863 0.77 CHRM1 (0.52) GPR119GRM4CHRM1PANK3SPR
SCHEMBL31289277 0.76 GPR119 (0.56) GPR119PANK3KDM4EALDH1A1L3MBTL1
SCHEMBL12683422 0.75 KDM4E (0.54) GPR119GRM4CHRM1PANK3KDM4E
SCHEMBL16718810 0.75 KDM4E (0.50) GPR119GRM4PANK3KDM4EALDH1A1
SCHEMBL29940306 0.75 KDM4E (0.50) GPR119GRM4PANK3KDM4EALDH1A1
SCHEMBL16478649 0.75 KDM4E (0.54) GPR119GRM4CHRM1PANK3KDM4E
SCHEMBL20355749 0.74 PANK3 (0.50) GPR119PANK3KDM4EALDH1A1L3MBTL1
SCHEMBL16627291 0.74 HRH3 (0.61) GPR119PARP1PANK3KDM4EALDH1A1
SCHEMBL30546437 0.74 CHRNB2 (0.48) GPR119PARP1PANK3KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021086077-A1 ISOQUINOLINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION, COMPRISING SAME AS ACTIVE INGREDIENT, FOR PREVENTION OR TREATMENT OF POLY(ADP-RIBOSE)POLYMERASE-1 (PARP-1)-ASSOCIATED DISEASE 충남대학교 산학협력단 2021-05-06 WO disclosed